Gabelli & Co Investment Advisers’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-508,950
Closed -$8.5M 304
2022
Q4
$8.5M Buy
508,950
+286,800
+129% +$4.84M 1.81% 19
2022
Q3
$3.81M Buy
+222,150
New +$3.49M 0.49% 43

Gabelli & Co Investment Advisers's ONEM Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 508,950 shares — an estimated $8.5M sold.

Gabelli & Co Investment Advisers first reported a position in ONEM in Q3 2022 and held it in 2 quarters. The position peaked at $8.5M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Gabelli & Co Investment Advisers reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 508,950 1Life Healthcare shares in Q1 2023, an estimated $8.5M.
  • Gabelli & Co Investment Advisers first reported a position in 1Life Healthcare in Q3 2022 and held it in 2 quarters.
  • Gabelli & Co Investment Advisers's 1Life Healthcare position peaked at $8.5M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.